Harmonized blood toxicity monitoring needed for Lu-177 DOTATATE patients
Peptide receptor radionuclide therapy has transformed the outlook for patients with metastatic neuroendocrine tumors, delivering targeted radiation to tumor cells while sparing much of the...
















